Loading clinical trials...
Loading clinical trials...
A Single Center, Randomized, Double-blind, Single Dose Bioequivalence Trial of Genakumab in Chinese Healthy Male Adults
Conditions
Interventions
Genakumab Injection (T, Solution for injection)
Genakumab for Injection (R, Powder for solution for injection)
Locations
1
China
Chengdu Xinhua Hospital
Chengdu, Sichuan, China
Start Date
June 24, 2024
Primary Completion Date
November 29, 2024
Completion Date
January 10, 2025
Last Updated
February 11, 2025
Lead Sponsor
Changchun GeneScience Pharmaceutical Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions